IDEAS home Printed from https://ideas.repec.org/a/spr/eujhec/v18y2017i4d10.1007_s10198-016-0801-6.html
   My bibliography  Save this article

A comprehensive approach to assess the costs of renal replacement therapy for end-stage renal disease in France: the importance of age, diabetes status, and clinical events

Author

Listed:
  • Anne-Line Couillerot-Peyrondet

    (Service évaluation économique et santé publique. Haute Autorité de Santé)

  • Cléa Sambuc

    (Service évaluation économique et santé publique. Haute Autorité de Santé)

  • Yoël Sainsaulieu

    (Pôle Organisation et Financement des Activités de Soins. Agence de la biomédecine)

  • Cécile Couchoud

    (REIN registry. Agence de la biomédecine)

  • Isabelle Bongiovanni-Delarozière

    (Service évaluation économique et santé publique. Haute Autorité de Santé)

Abstract

Objectives In the current pressured economic context, and to continue to treat the growing number of patients with high-quality standards, the first step is to have a better understanding of the costs related to end-stage renal disease (ESRD) treatment according to various renal replacement therapy, age, diabetes status, and clinical events. Methods In order to estimate the direct costs of all adult ESRD patients, according to (RRT) modality, patient condition, and clinical events, data from the French national health insurance funds were used. Results The mean monthly costs for the 47,862 stable prevalent patients (73 % of the population) varied substantially according to treatment modality (from 7300€ for in-center hemodialysis to 1100€ for a functioning renal graft) and to clinical event (8300€ for the first month of dialysis, 11,000€ for the last month before death, 22,800€ for the first month after renal transplantation). Mean monthly costs varied according to diabetic status and to age to a lesser extent. Conclusions These results demonstrate, for the first time in France and in Europe, the importance of a dynamic view of renal care and the bias likely when comparing treatments in cross-sectional studies.

Suggested Citation

  • Anne-Line Couillerot-Peyrondet & Cléa Sambuc & Yoël Sainsaulieu & Cécile Couchoud & Isabelle Bongiovanni-Delarozière, 2017. "A comprehensive approach to assess the costs of renal replacement therapy for end-stage renal disease in France: the importance of age, diabetes status, and clinical events," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 18(4), pages 459-469, May.
    • Handle: RePEc:spr:eujhec:v:18:y:2017:i:4:d:10.1007_s10198-016-0801-6
    DOI: 10.1007/s10198-016-0801-6
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s10198-016-0801-6
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1007/s10198-016-0801-6?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Toni Ashton & Mark Marshall, 2007. "The organization and financing of dialysis and kidney transplantation services in New Zealand," International Journal of Health Economics and Management, Springer, vol. 7(4), pages 233-252, December.
    2. Peeters, Pascale & Rublee, Dale & Just, Paul M. & Joseph, Alain, 2000. "Analysis and interpretation of cost data in dialysis: review of Western European literature," Health Policy, Elsevier, vol. 54(3), pages 209-227, December.
    3. Chris P. Lee & Glenn M. Chertow & Stefanos A. Zenios, 2006. "A Simulation Model to Estimate the Cost and Effectiveness of Alternative Dialysis Initiation Strategies," Medical Decision Making, , vol. 26(5), pages 535-549, September.
    4. Braden Manns & David Mendelssohn & Kenneth Taub, 2007. "The economics of end-stage renal disease care in Canada: incentives and impact on delivery of care," International Journal of Health Economics and Management, Springer, vol. 7(2), pages 149-169, September.
    5. Just, Paul Michael & Riella, Miguel Carlos & Tschosik, Elizabeth Ann & Noe, Leslie Lyle & Bhattacharyya, Samir Kumar & de Charro, Frank, 2008. "Economic evaluations of dialysis treatment modalities," Health Policy, Elsevier, vol. 86(2-3), pages 163-180, May.
    6. Wim Biesen & Norbert Lameire & Patrick Peeters & Raymond Vanholder, 2007. "Belgium’s mixed private/public health care system and its impact on the cost of end-stage renal disease," International Journal of Health Economics and Management, Springer, vol. 7(2), pages 133-148, September.
    7. Avi Dor & Mark V. Pauly & Margaret A. Eichleay & Philip J. Held, 2007. "End-stage Renal Disease and Economic Incentives: The International Study of Health Care Organization and Financing," NBER Working Papers 13125, National Bureau of Economic Research, Inc.
    8. Giuseppe Pontoriero & Pietro Pozzoni & Lucia Vecchio & Francesco Locatelli, 2007. "International Study of Health Care Organization and Financing for renal replacement therapy in Italy: an evolving reality," International Journal of Health Economics and Management, Springer, vol. 7(2), pages 201-215, September.
    9. Richard Hirth, 2007. "The organization and financing of kidney dialysis and transplant care in the United States of America," International Journal of Health Economics and Management, Springer, vol. 7(4), pages 301-318, December.
    10. Polder, Johan J. & Barendregt, Jan J. & van Oers, Hans, 2006. "Health care costs in the last year of life--The Dutch experience," Social Science & Medicine, Elsevier, vol. 63(7), pages 1720-1731, October.
    11. Avi Dor & Mark Pauly & Margaret Eichleay & Philip Held, 2007. "End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF)," International Journal of Health Economics and Management, Springer, vol. 7(2), pages 73-111, September.
    12. Office of Health Economics, 2007. "The Economics of Health Care," For School 001490, Office of Health Economics.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Björn Wikström & Michael Fored & Margaret Eichleay & Stefan Jacobson, 2007. "The financing and organization of medical care for patients with end-stage renal disease in Sweden," International Journal of Health Economics and Management, Springer, vol. 7(4), pages 269-281, December.
    2. Avi Dor & Mark Pauly & Margaret Eichleay & Philip Held, 2007. "End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF)," International Journal of Health Economics and Management, Springer, vol. 7(2), pages 73-111, September.
    3. Werner Kleophas & Helmut Reichel, 2007. "International study of health care organization and financing: development of renal replacement therapy in Germany," International Journal of Health Economics and Management, Springer, vol. 7(2), pages 185-200, September.
    4. José Luño, 2007. "The organization and financing of end-stage renal disease in Spain," International Journal of Health Economics and Management, Springer, vol. 7(4), pages 253-267, December.
    5. Isabelle Durand-Zaleski & Christian Combe & Philippe Lang, 2007. "International Study of Health Care Organization and Financing for end-stage renal disease in France," International Journal of Health Economics and Management, Springer, vol. 7(2), pages 171-183, September.
    6. Tricia Nicholson & Paul Roderick, 2007. "International Study of Health Care Organization and Financing of renal services in England and Wales," International Journal of Health Economics and Management, Springer, vol. 7(4), pages 283-299, December.
    7. Cleemput, Irina & De Laet, Chris, 2013. "Analysis of the costs of dialysis and the effects of an incentive mechanism for low-cost dialysis modalities," Health Policy, Elsevier, vol. 110(2), pages 172-179.
    8. Shunichi Fukuhara & Chikao Yamazaki & Yasuaki Hayashino & Takahiro Higashi & Margaret Eichleay & Takashi Akiba & Tadao Akizawa & Akira Saito & Friedrich Port & Kiyoshi Kurokawa, 2007. "The organization and financing of end-stage renal disease treatment in Japan," International Journal of Health Economics and Management, Springer, vol. 7(2), pages 217-231, September.
    9. Avi Dor & Mark V. Pauly & Margaret A. Eichleay & Philip J. Held, 2007. "End-stage Renal Disease and Economic Incentives: The International Study of Health Care Organization and Financing," NBER Working Papers 13125, National Bureau of Economic Research, Inc.
    10. Wim Biesen & Norbert Lameire & Patrick Peeters & Raymond Vanholder, 2007. "Belgium’s mixed private/public health care system and its impact on the cost of end-stage renal disease," International Journal of Health Economics and Management, Springer, vol. 7(2), pages 133-148, September.
    11. Chang, Ray-E. & Hsieh, Chi-Jeng & Myrtle, Robert C., 2011. "The effect of outpatient dialysis global budget cap on healthcare utilization by end-stage renal disease patients," Social Science & Medicine, Elsevier, vol. 73(1), pages 153-159, July.
    12. Braden Manns & David Mendelssohn & Kenneth Taub, 2007. "The economics of end-stage renal disease care in Canada: incentives and impact on delivery of care," International Journal of Health Economics and Management, Springer, vol. 7(2), pages 149-169, September.
    13. Toni Ashton & Mark Marshall, 2007. "The organization and financing of dialysis and kidney transplantation services in New Zealand," International Journal of Health Economics and Management, Springer, vol. 7(4), pages 233-252, December.
    14. Anthony Harris, 2007. "The organization and funding of the treatment of end-stage renal disease in Australia," International Journal of Health Economics and Management, Springer, vol. 7(2), pages 113-132, September.
    15. Alan M. Garber & Jonathan Skinner, 2008. "Is American Health Care Uniquely Inefficient?," NBER Working Papers 14257, National Bureau of Economic Research, Inc.
    16. Giuseppe Pontoriero & Pietro Pozzoni & Lucia Vecchio & Francesco Locatelli, 2007. "International Study of Health Care Organization and Financing for renal replacement therapy in Italy: an evolving reality," International Journal of Health Economics and Management, Springer, vol. 7(2), pages 201-215, September.
    17. Wong, Albert & Wouterse, Bram & Slobbe, Laurentius C.J. & Boshuizen, Hendriek C. & Polder, Johan J., 2012. "Medical innovation and age-specific trends in health care utilization: Findings and implications," Social Science & Medicine, Elsevier, vol. 74(2), pages 263-272.
    18. Alan M. Garber & Jonathan Skinner, 2008. "Is American Health Care Uniquely Inefficient?," Journal of Economic Perspectives, American Economic Association, vol. 22(4), pages 27-50, Fall.
    19. Vincenzo Atella & Valentina Conti, 2013. "The effect of age and time to death on health care expenditures: the Italian experience," CEIS Research Paper 267, Tor Vergata University, CEIS, revised 12 Nov 2013.
    20. Gregersen, Fredrik Alexander & Godager, Geir, 2013. "Hospital expenditures and the red herring hypothesis: Evidence from a complete national registry," HERO Online Working Paper Series 2013:3, University of Oslo, Health Economics Research Programme.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:eujhec:v:18:y:2017:i:4:d:10.1007_s10198-016-0801-6. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.